CN103611093A - Traditional Chinese medicine composition for treating lung cancer - Google Patents
Traditional Chinese medicine composition for treating lung cancer Download PDFInfo
- Publication number
- CN103611093A CN103611093A CN201310669278.3A CN201310669278A CN103611093A CN 103611093 A CN103611093 A CN 103611093A CN 201310669278 A CN201310669278 A CN 201310669278A CN 103611093 A CN103611093 A CN 103611093A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating lung cancer. According to the traditional Chinese medicine composition, the living quality and survival rate can be improved. The raw material medicines consist of the following components: loquat kernel, lalang grass rhizome, exocarpium, apricot kernel, hickory, adenophora tetraphylla, radix glehniae, radix pseudostellariae, radix scrophulariae, radix ophiopogonis, semen litchi, rhizoma sparganii, curcuma zedoary, glossy privet fruit, fritillaria thun-bergli, astragalus, subprostrate sophora, pangolin, scutellaria baicalensis, cornu bubali, platycodon grandiflorum, rhizoma polygonati, pseudo-ginseng, lucid ganoderma, the root of bidentate achyranthes, selaginella doederleinii Hieron, asparagus, schisandra chinensis, oldenlandia diffusa and houttuynia cordata. The traditional Chinese medicine composition consists of multiple Chinese herbal medicines with an anti-cancer effect; compared with a general chemical medicine, the traditional Chinese medicine composition has the characteristic of small toxic or side effect, the anti-cancer effect is obvious, and the complication occurrence rate of the patient can be effectively reduced, so that the cure rate of the patient with lung cancer is improved.
Description
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition of the treatment pulmonary carcinoma being formed by the multiple Chinese herbal medicine with anticancer function.
Background technology
Pulmonary carcinoma is a kind of disease, it is characterized by paracytic growth out of control, and is spread to other position by original site, this diffusion is as uncontrollable, by infringement critical organ and then cause exhaustion, finally cause death, become one of maximum public health problem in the whole world.Patients with lung cancer generally adopts the therapeutic alliance of operation, chemotherapy, radiotherapy, wherein chemotherapy is unique whole body therapeutic means, the postoperative important measures that prevent diffusion, prevention of recurrence, also be to lose the most effectively Therapeutic Method that the Patients with Advanced Lung Cancer of operative treatment chance can be selected, therefore chemotherapy has core status in antineoplaston, and has whole process.The curative effect of chemotherapy is sure, but chemotherapeutics belongs to cytotoxic drug, has certain toxicity.Be mainly manifested in three aspects: be first all presumable side effect of most of chemotherapeutics, such as leukocyte decline, vomiting and alopecia etc., the place that these side effect occur is mainly that the growth fractions such as bone marrow, gastrointestinal mucosa and hair follicle are organized faster, these side effect will soon occur when chemotherapy, although stop comparatively fast recovering after chemotherapy, some patients were has to adjust even abandoning cure of dosage because tolerating; Next is the side effect that indivedual medicines cause specific system, and such as anthracene nucleus medicament can cause cardiac toxicity, bleomycin can affect respiratory system etc. will cause clinical unexpected generation; The 3rd is side effect at a specified future date, commonly carcinogenic on impact and the secondary of fertility system.The side effect causing is serious and obvious, and these untoward reaction have limited its clinical practice and curative effect.
Huge contribution has been made in the procreation health care of the Chinese Traditional Medicine applicating history ，Wei Chinese nation of existing thousands of years.Its primary treatment medicament sources is in natural drug, and due to determined curative effect, untoward reaction is slight, is progressively familiar with just in the world and accepts.TCM Oncology has driven the development of the basic and clinic studies of Chinese medicine medicine for preventing as clinical speciality independently, from clinical practice situation, Chinese traditional treatment has obvious effect to improving modern antineoplaston effect, mitigation symptoms and improving patients ' life quality and extend the aspects such as time-to-live.
Summary of the invention
The object of the invention is the defect existing in order to overcome prior art, deficiency for existing clinical antineoplaston, a kind of medicine of take the treatment pulmonary carcinoma that Chinese crude drug is waste is provided, and its curative effect is high, symptom alleviates obviously, can improve patients ' life quality and extend the time-to-live.
In order to realize object of the present invention, the present invention adopts following scheme:
Treat a Chinese medicine composition for pulmonary carcinoma, the crude drug of its Chinese medicine is comprised of the component of following weight parts proportioning:
40～70 parts of Radix Eriobotryaes, 30～45 parts of Rhizoma Imperataes, 50～60 parts of Exocarpium Citri Grandises, 150～180 parts of Semen Armeniacae Amarum, 22～25 parts of Semen Caryae Cathayensis, 40～44 parts of Radix Adenophoraes, 40～44 parts of Radix Glehniaes, 40～44 parts of Radix Pseudostellariaes, 40～44 parts of Radix Scrophulariaes, 38～42 parts of Radix Ophiopogonis, 30～35 parts of Semen Litchis, 35～40 parts of Rhizoma Sparganii, 35～40 parts of Rhizoma Curcumae, 50～65 parts of Fructus Ligustri Lucidi, 50～65 parts of Bulbus Fritillariae Uninbracteataes, 160～180 parts of the Radixs Astragali, 70～90 parts of Radix Sophorae Tonkinensiss, 65～70 parts of Squama Maniss, 47～50 parts of Radix Scutellariaes, 30～34 parts of Cornu Bubalis, 60～65 parts of Radix Platycodoniss, 70～80 parts of Rhizoma Polygonatis, 35～42 parts of Radix Notoginseng, 40～45 parts of Ganodermas, 28～32 parts of Radix Achyranthis Bidentataes, 28～32 parts of Herba Selaginellae Doederleiniis, 90～100 parts of asparaguss, 30～33 parts of Fructus Schisandrae Chinensis, 40～45 parts of Herba Hedyotidis Diffusaes, 36～42 parts of Herba Houttuyniae.
In some embodiment, the crude drug of described Chinese medicine is comprised of the component of following weight parts proportioning therein:
50 parts of Radix Eriobotryaes, 30 parts of Rhizoma Imperataes, 60 parts of Exocarpium Citri Grandises, 160 parts of Semen Armeniacae Amarum, 22 parts of Semen Caryae Cathayensis, 44 parts of Radix Adenophoraes, 44 parts of Radix Glehniaes, 44 parts of Radix Pseudostellariaes, 44 parts of Radix Scrophulariaes, 38 parts of Radix Ophiopogonis, 30 parts of Semen Litchis, 38 parts of Rhizoma Sparganii, 38 parts of Rhizoma Curcumae, 55 parts of Fructus Ligustri Lucidi, 55 parts of Bulbus Fritillariae Uninbracteataes, 180 parts of the Radixs Astragali, 80 parts of Radix Sophorae Tonkinensiss, 66 parts of Squama Maniss, 49 parts of Radix Scutellariaes, 30 parts of Cornu Bubalis, 60 parts of Radix Platycodoniss, 80 parts of Rhizoma Polygonatis, 40 parts of Radix Notoginseng, 45 parts of Ganodermas, 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Selaginellae Doederleiniis, 100 parts of asparaguss, 30 parts of Fructus Schisandrae Chinensis, 40 parts of Herba Hedyotidis Diffusaes, 41 parts of Herba Houttuyniae.
Radix Eriobotryae: hardship, flat;
Cure mainly: preventing phlegm from forming and stopping coughing, depressed liver-energy dispersing and QI regulating.Control cough, hernia, edema, scrofula.
Rhizoma Imperatae: sweet in the mouth, cold;
Cure mainly: cooling blood for hemostasis, heat-clearing and toxic substances removing.For spitting blood, hematuria, pyretic stranguria, edema, jaundice, dysuria, calentura excessive thirst, the gastric heat sound of vomiting of vomitting, coughs.
Exocarpium Citri Grandis: nature and flavor are bitter, pungent, warm;
Cure mainly: reduce phlegm, regulating qi-flowing for strengthening spleen, help digestion, control that expectorant is stagnant in the heart, cough and asthma, vomiting singultus, eating accumulation.
Semen Armeniacae Amarum: bitter in the mouth;
Cure mainly: expelling phlegm for arresting cough, intestine moistening.
Semen Caryae Cathayensis: sweet in the mouth, gas is fragrant;
Cure mainly: lung moistening QI invigorating, nourish blood relieving asthma, moistening the lung and resolving the phlegm goes all effects of deficiency and coldness.
Radix Adenophorae: sweet light, property is flat;
Cure mainly: the gas of tonifying the lung spleen, be applicable to deficiency of both the splenic and pulmonary QI, clearing away heat and nourishing YIN, nourishing the lung to arrest cough, cures mainly tracheitis, pertussis, cough due to lung-heat, coughs up phlegm yellow thick, light red tongue, arteries and veins weak person.
Radix Glehniae: sweet cold;
Cure mainly: kind the moon of supporting lung stomach, be applicable to calentura later stage or prolonged illness yin asthenia generating intrinsic heat, dry cough, expectorant is few, low grade fever, xerostomia, red tongue, tongue is few, thready pulse weak person.
Radix Pseudostellariae: sweet, micro-hardship, flat;
Cure mainly: the diseases such as insufficiency of the spleen lack of appetite, fatigue and weakness, cardiopalmus spontaneous perspiration, cough due to deficiency of the lung, thirst due to body fluid deficiency.
Radix Scrophulariae: sweet in the mouth, hardship, salty;
Cure mainly: the diseases such as consumption of body fluid caused by febrile disease, excessive thirst constipation, laryngopharynx swelling and pain, scrofula, maculae caused by violent heat pathogen.
Radix Ophiopogonis: sweet, micro-hardship;
Cure mainly: Yin-nourishing and body fluid promoting, nourishing the lung to arrest cough, relieving restlessness clears away heart-fire.
Semen Litchi: acrid in the mouth, hardship;
Cure mainly: promoting QI to circulate and dispersing the agglomeration of the pathogens, cold-dispelling pain-relieving.
Rhizoma Sparganii: acrid in the mouth is puckery, cool;
Cure mainly: control lump in the abdomen, gather, distending pain over the hypochondrium, food stagnation distending pain, dysmenorrhea.
Rhizoma Curcumae: mildly bitter flavor, feeble QI is fragrant;
Cure mainly: coagulation of QI-blood, trusted subordinate's distending pain, lump in the abdomen, gathers, and dyspepsia does not disappear, traumatic injury.
Fructus Ligustri Lucidi: odorless, sweet in the mouth, micro-bitterness;
Cure mainly: poor vision, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.
Bulbus Fritillariae Uninbracteatae: bitter, sweet, be slightly cold;
Cure mainly: relieving cough and resolving phlegm, heat clearing away eliminating stagnation.
The Radix Astragali: slightly warm in nature, sweet in the mouth.
Cure mainly: deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.
Radix Sophorae Tonkinensis: hardship, cold;
Cure mainly: control retropharyngeal abscess, acute throat trouble, sore throat, gingival swelling and pain, dyspnea with fullness of the chest heat syndrome cough, jaundice, dysentery.
Squama Manis: cold nature, salty in the mouth.
Cure mainly: blood circulation promoting and dispersing pathogen accumulation, the stimulating milk secretion of stimulating the menstrual flow, eliminating carbuncle are burst hard.Main blood stasis amenorrhea, lump in the abdomen, rheumatic arthralgia, agalactia, carbuncle, scrofula.
Radix Scutellariae: bitter in the mouth, cold in nature;
Cure mainly: heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.
Cornu Bubali: bitter salty, cold;
Cure mainly: heat clearing away, removing heat from blood, arresting convulsion, removing toxic substances.
Radix Platycodonis: bitter in the mouth, pungent, slightly warm in nature;
Cure mainly: eliminating phlegm and stopping cough, lung qi dispersing, evacuation of pus.
Rhizoma Polygonati: sweet, flat;
Cure mainly: weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, the interior-heat disease such as quench one's thirst.
Radix Notoginseng: sweet in the mouth, micro-hardship, warm in nature;
Cure mainly: fall and flutter congestive edema, thoracic obstruction angor, lump in the abdomen; Blood stasis amenorrhea; Dysmenorrhea; The cloudy stomachache of the stasis of blood in puerperal; Sore, carbuncle and painful swelling.
Ganoderma: property is flat, bitter in the mouth;
Cure mainly: asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.
Radix Achyranthis Bidentatae: property is flat, bitter in the mouth, acid.
Cure mainly: invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards., amenorrhea lump in the abdomen unable for soreness of waist and knee joint, muscles and bones, dizziness due to hyperactivity of liver-YANG.
Herba Selaginellae Doederleinii: sweet in the mouth, micro-hardship, puckery, cool in nature;
Cure mainly: heat-clearing and toxic substances removing, expelling wind and removing dampness, hemostasis, the effect such as anticancer.
Asparagus: asparagus is Germinatus Phragmitis, cool, sweet, bitter;
Cure mainly: lung moistening antitussive, parasite killing eliminates the phlegm.
Fructus Schisandrae Chinensis: temperature, acid, sweet;
Cure mainly: astringe the lung, nourishing kidney, promotes the production of body fluid, receive antiperspirant, arresting seminal emission.
Herba Hedyotidis Diffusae: bitter, light, cold in nature;
Cure mainly: heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Herba Houttuyniae: cold nature, bitter in the mouth;
Cure mainly: the main lung abscess vomiting pus of pyretic stranguria; Expectorant dyspnea of heat type is coughed; Hematodiarrhoea; Carbuncle sore tumefacting virus; Pyretic stranguria.
In some embodiment, described Chinese medicine composition can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) through extracting, mixing therein; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
In some embodiment, the mixture of the effective ingredient of described Chinese medicine composition after extracting, can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) therein; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
A kind of medicine for the treatment of pulmonary carcinoma of the present invention, it is the Chinese herbal medicine that there is anticancer function by multiple, through with other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, be mainly used in the treatment of pulmonary carcinoma, there is rapid-action, good effect, the features such as taking convenience, and compare and have the advantages that toxic and side effects is little with general chemicals.The effect that it is anticancer, except showing effective anticancer, can also strengthen patient's immunity, improve hemorheology index, change oncogene expression, cancer cell specific induction of apoptosis, anticancer propagation, and can reduce patient's injury that normal structure is subject to when accepting the treatment meanss such as chemotherapy, radiotherapy, reduce the incidence rate of complication for patients, thereby improve the cure rate of patients with lung cancer, reduce the mortality rate of pulmonary carcinoma.
The specific embodiment
For further understanding feature of the present invention, technological means and the specific purposes that reach, function, below in conjunction with the specific embodiment, the present invention is described in further detail.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention can suitably be adjusted according to the variations such as the order of severity of route of administration, patient individual difference, clinical application and disease, and the crude drug of Chinese medicine is comprised of the component of following weight parts proportioning:
50 parts of Radix Eriobotryaes, 30 parts of Rhizoma Imperataes, 60 parts of Exocarpium Citri Grandises, 160 parts of Semen Armeniacae Amarum, 22 parts of Semen Caryae Cathayensis, 44 parts of Radix Adenophoraes, 44 parts of Radix Glehniaes, 44 parts of Radix Pseudostellariaes, 44 parts of Radix Scrophulariaes, 38 parts of Radix Ophiopogonis, 30 parts of Semen Litchis, 38 parts of Rhizoma Sparganii, 38 parts of Rhizoma Curcumae, 55 parts of Fructus Ligustri Lucidi, 55 parts of Bulbus Fritillariae Uninbracteataes, 180 parts of the Radixs Astragali, 80 parts of Radix Sophorae Tonkinensiss, 66 parts of Squama Maniss, 49 parts of Radix Scutellariaes, 30 parts of Cornu Bubalis, 60 parts of Radix Platycodoniss, 80 parts of Rhizoma Polygonatis, 40 parts of Radix Notoginseng, 45 parts of Ganodermas, 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Selaginellae Doederleiniis, 100 parts of asparaguss, 30 parts of Fructus Schisandrae Chinensis, 40 parts of Herba Hedyotidis Diffusaes, 41 parts of Herba Houttuyniae.Its every daily dose is counted 5g ~ 50g by crude drug, and preferred every daily dose is 15g ~ 30g, can once or several times use
Crude drug is obtained through pulverizing to extract to be mixed with by Chinese crude drug or its extract, and making pharmaceutical preparation is tablet, capsule, granule, pill etc.
Instructions about how to take medicine: warm water takes.One day 3 times, one time 6, a 0.3g ~ 1g, observes by the long-term follow of out-patient's 15 examples, transference cure, the no longer medication of 12 examples, cure rate is up to 80%.
Successful case:
Patient Lee * * (man) did routine blood test, the inspection such as biochemical conventional in January, 2013, and lung tumor antigen related assays, CA15-3:40.41 U/mL in lung tumor antigen related assays wherein, CEA:188.1 ng/mL severe overweight.
2013-01-11 Chest Image CT report: patient's superior lobe of right lung soft tissue agglomerate shadow, greatest cross-section is 48 * 33mm approximately, and focus and the boundary of upper right hilus pulumonis are unclear, the big or small approximately lesser tubercle soft-tissue density shadow of 13 * 11mm of blade tip Duan Yijian mono-on its adjacent rear.Companion's focus is scorching around, lymphangitis carcinomatosa, the multiple lymphatic metastasis of mediastinum.
2013-01-16 breast, upper abdomen CT be unenhanced+strengthen audit report: and a swollen thing is shown in by superior lobe of right lung, and size is 49 * 59mm approximately, and focus is shown in multiple patch shape around, class nodositas focus, the maximum is 13 * 17mm approximately, obscure boundary.Bilateral supraclavicular fossa, mediastinum, the multiple lymph node of right lung door, the maximum is 11 * 16mm approximately.The multiple focus of thyroid bilobate, the maximum is 10 * 6mm approximately.Calculus in liver S7 bile duct.
2013-01-16 thoracic ultrasound report: supraclavicular region, right side can be visited and multiple lymph node, more about 14 * 13mm, border is clear, circle, lymph door disappears.
Patient, from February, 2013, takes medicine after three months, and sb.'s illness took a favorable turn, and foci disappearance does not need to have taken medicine, and returns to one's perfect health.
Patient Sun Xiansheng in JIUYUE, 2011, patient is because of cough, expectoration, and apoplexy due to phlegm is admission examination with blood.While having a medical check-up, CT finds right upper lung solitary nodule, and size is 2.0 * 2.0cm, considers that pulmonary carcinoma probability is large.
Because can not be clear and definite whether be pulmonary carcinoma, therefore be again PET/CT, check.PET/CT finding: the dense poly-kitchen range of right upper lung nodositas radioactivity, intralesional increased radioactivity is even, clear border, SUV is 2.8.
PET/CT diagnosis: right upper lung nodositas hypermetabolism kitchen range, is thought of as pulmonary carcinoma.
Pathological diagnosis: lung squamous cancer (being more common in central type carcinoma of lung).
Patient took medicine after four months, and focus is controlled, and did not breathe heavily and did not cough, and can return company working, did not need to take that other is medicinal, drug withdrawal.
The above embodiment has only expressed several embodiment of the present invention, and it describes comparatively concrete and detailed, but can not therefore be interpreted as the restriction to the scope of the claims of the present invention.It should be pointed out that for the person of ordinary skill of the art, without departing from the inventive concept of the premise, can also make some distortion and improvement, these all belong to protection scope of the present invention.Therefore, the protection domain of patent of the present invention should be as the criterion with claims.
Claims (4)
1. a Chinese medicine composition for the treatment of pulmonary carcinoma, is characterized in that, the crude drug of its Chinese medicine is comprised of the component of following weight parts proportioning:
40～70 parts of Radix Eriobotryaes, 30～45 parts of Rhizoma Imperataes, 50～60 parts of Exocarpium Citri Grandises, 150～180 parts of Semen Armeniacae Amarum, 22～25 parts of Semen Caryae Cathayensis, 40～44 parts of Radix Adenophoraes, 40～44 parts of Radix Glehniaes, 40～44 parts of Radix Pseudostellariaes, 40～44 parts of Radix Scrophulariaes, 38～42 parts of Radix Ophiopogonis, 30～35 parts of Semen Litchis, 35～40 parts of Rhizoma Sparganii, 35～40 parts of Rhizoma Curcumae, 50～65 parts of Fructus Ligustri Lucidi, 50～65 parts of Bulbus Fritillariae Uninbracteataes, 160～180 parts of the Radixs Astragali, 70～90 parts of Radix Sophorae Tonkinensiss, 65～70 parts of Squama Maniss, 47～50 parts of Radix Scutellariaes, 30～34 parts of Cornu Bubalis, 60～65 parts of Radix Platycodoniss, 70～80 parts of Rhizoma Polygonatis, 35～42 parts of Radix Notoginseng, 40～45 parts of Ganodermas, 28～32 parts of Radix Achyranthis Bidentataes, 28～32 parts of Herba Selaginellae Doederleiniis, 90～100 parts of asparaguss, 30～33 parts of Fructus Schisandrae Chinensis, 40～45 parts of Herba Hedyotidis Diffusaes, 36～42 parts of Herba Houttuyniae.
2. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, the crude drug of described Chinese medicine is comprised of the component of following weight parts proportioning:
50 parts of Radix Eriobotryaes, 30 parts of Rhizoma Imperataes, 60 parts of Exocarpium Citri Grandises, 160 parts of Semen Armeniacae Amarum, 22 parts of Semen Caryae Cathayensis, 44 parts of Radix Adenophoraes, 44 parts of Radix Glehniaes, 44 parts of Radix Pseudostellariaes, 44 parts of Radix Scrophulariaes, 38 parts of Radix Ophiopogonis, 30 parts of Semen Litchis, 38 parts of Rhizoma Sparganii, 38 parts of Rhizoma Curcumae, 55 parts of Fructus Ligustri Lucidi, 55 parts of Bulbus Fritillariae Uninbracteataes, 180 parts of the Radixs Astragali, 80 parts of Radix Sophorae Tonkinensiss, 66 parts of Squama Maniss, 49 parts of Radix Scutellariaes, 30 parts of Cornu Bubalis, 60 parts of Radix Platycodoniss, 80 parts of Rhizoma Polygonatis, 40 parts of Radix Notoginseng, 45 parts of Ganodermas, 30 parts of Radix Achyranthis Bidentataes, 30 parts of Herba Selaginellae Doederleiniis, 100 parts of asparaguss, 30 parts of Fructus Schisandrae Chinensis, 40 parts of Herba Hedyotidis Diffusaes, 41 parts of Herba Houttuyniae.
3. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, described Chinese medicine composition is through extracting, being mixed with as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
4. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, the mixture of the effective ingredient of described Chinese medicine composition after extracting, is prepared as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutical preparation that pharmaceutically acceptable pharmaceutical carrier or mixed with excipients form, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310669278.3A CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310669278.3A CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103611093A true CN103611093A (en) | 2014-03-05 |
| CN103611093B CN103611093B (en) | 2015-10-28 |
Family
ID=50161826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310669278.3A Active CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103611093B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524374A (en) * | 2014-12-30 | 2015-04-22 | 潘振奎 | Traditional Chinese medicine formula for treating lung cancer and preparation method of traditional Chinese medicine formula |
| CN107789478A (en) * | 2017-12-21 | 2018-03-13 | 曹国荣 | Eliminate pharmaceutical composition of cancer patient's deficiency of Yin accumulation stool and preparation method thereof |
| CN111329949A (en) * | 2020-03-05 | 2020-06-26 | 周口师范学院 | Medicine composition for treating lung cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1092523C (en) * | 1999-06-23 | 2002-10-16 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
| CN101584801A (en) * | 2008-05-19 | 2009-11-25 | 尚爱永 | Traditional Chinese medicine for treating primary lung cancer |
| CN102949679A (en) * | 2012-12-04 | 2013-03-06 | 周玉娟 | Medicine for curing lung cancer and preparation method thereof |
-
2013
- 2013-12-11 CN CN201310669278.3A patent/CN103611093B/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524374A (en) * | 2014-12-30 | 2015-04-22 | 潘振奎 | Traditional Chinese medicine formula for treating lung cancer and preparation method of traditional Chinese medicine formula |
| CN107789478A (en) * | 2017-12-21 | 2018-03-13 | 曹国荣 | Eliminate pharmaceutical composition of cancer patient's deficiency of Yin accumulation stool and preparation method thereof |
| CN111329949A (en) * | 2020-03-05 | 2020-06-26 | 周口师范学院 | Medicine composition for treating lung cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103611093B (en) | 2015-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103611093B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
| CN103463554B (en) | A kind of treat malignant tumor pharmaceutical composition and preparation method and purposes | |
| CN103263587B (en) | Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof | |
| CN104984267A (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN103721196A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN103611091A (en) | Traditional Chinese medicine composition for treating pancreatic cancer | |
| CN103055266A (en) | Chinese medicinal herb composition for treating liver cancer and preparation method thereof | |
| CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
| CN104800510A (en) | Traditional Chinese medicine composition for treating stomach cancer | |
| CN104257977A (en) | Traditional Chinese medicine preparation for treating liver-stomach disharmony type chronic superficial gastritis | |
| CN104784508B (en) | For improving the preparation method of the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN104758488A (en) | Traditional Chinese medicine composition for treating hepatic hemangioma caused by qi stagnation and blood stasis | |
| CN104623450A (en) | Traditional Chinese medicine preparation for treating breast cancer | |
| CN103989994A (en) | Pharmaceutical preparation for treating chronic urticaria | |
| CN104784509B (en) | For improving the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN103877397B (en) | A kind of medicine of radiotherapy injury of lung and preparation method | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN102961704A (en) | Pharmaceutical composition for treating liver caner and method for preparing dispersible tablets thereof | |
| CN102000263B (en) | Traditional Chinese medicine preparation for treating lung cancer | |
| CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN105311468A (en) | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof | |
| CN105106798A (en) | Traditional Chinese medicine composition for preventing and treating ovarian cancer and preparation method thereof | |
| CN105535626A (en) | Traditional Chinese medicine for treating tuberculosis by combination with anti-tuberculosis western medicine | |
| CN104644981A (en) | Phlegm-eliminating and stagnation-dispersing agent for nasopharyngeal carcinoma and preparation method of phlegm-eliminating and stagnation-dispersing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| CB02 | Change of applicant information |
Address after: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd. Applicant after: DONGGUAN DONGZHUO ZHONGTIAN BIOTECHNOLOGY CO., LTD. Address before: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd. Applicant before: DONGGUAN SHENGHONG BIOTECHNOLOGY CO., LTD. |
|
| COR | Change of bibliographic data | ||
| GR01 | Patent grant |